Company profile
Amyl Therapeutics
Restoring clarity in amyloid diseases
- Industry
- Biotechnology Research
- Employees
- 11
- Headquarters
- Liège, Walloon Region
- Founded
- 2020
- LinkedIn followers
- 2,921
- Office locations
- 1
Amyl Therapeutics company summary
Amyl Therapeutics is a company in the Biotechnology Research industry, headquartered in Liège, Walloon Region, founded in 2020. On LinkedIn the company has around 11 employees and 2,921 followers. Its listed specialties include amyloidosis, Alzheimer, Parkinson, Biopharmaceutical research.
What technology does Amyl Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Amyl Therapeutics
Amyl therapeutics is a preclinical-stage biotechnology company pioneering a breakthrough approach to treating severe peripheral amyloid protein misfolding diseases. By developing novel therapies that recognize and target multiple misfolded proteins, we aim to make a transformative impact on the lives of patients affected by neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, or by systemic amyloidosis. Our approach is shaped by an experienced team with deep drug development experience, and productive collaborations with world-class advisors and partners.
Specialties
Where is Amyl Therapeutics located?
Amyl Therapeutics lists 1 location.
Compare companies similar to Amyl Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Amyl Therapeutics amyltx.com | Biotechnology Research | 11 | 2020 | Liège, Walloon Region |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Amyl Therapeutics
What does Amyl Therapeutics do?
Amyl therapeutics is a preclinical-stage biotechnology company pioneering a breakthrough approach to treating severe peripheral amyloid protein misfolding diseases. By developing novel therapies that recognize and target multiple misfolded proteins, we aim to make a transformative impact on the lives of patients affected by neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, or by systemic amyloidosis. Our approach is shaped by an experienced team with deep drug development experience, and productive collaborations with world-class advisors and partners.
How many employees does Amyl Therapeutics have?
Amyl Therapeutics has around 11 employees on LinkedIn.
Where is Amyl Therapeutics headquartered?
Amyl Therapeutics is headquartered in Liège, Walloon Region.
When was Amyl Therapeutics founded?
Amyl Therapeutics was founded in 2020.
Build a lead list from companies like Amyl Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.